Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retrovital vectors

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 2762-2769

  Lonning, S M ^a,b   Zhang, W ^a   Leib, S R ^a   Mcguire, T C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; GIBBON LEUKEMIA VIRUS; LENTIVIRINAE; LONG TERMINAL REPEAT; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS; TARGET CELL;

EID: 0033050745     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.2762-2769.1999     Document Type: Article

References (52)

1. Ball, J. M., S. L. Payne, C. J. Issel, and R. C. Montelaro. 1988. EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA. Virology 165:601-605.
2. Bennink, J. R., and J. W. Yewdell. 1990. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr. Top. Microbiol. Immunol. 163:153-184.
3. Burns, D. P., and R. C. Desrosiers. 1994. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence. Curr. Top. Microbiol. Immunol. 188:185-219.
4. Carpenter, S., L. H. Evans, M. Sevoian, and B. Chesebro. 1987. Role of the host immune response in selection of equine infectious anemia virus variants. J. Virol. 61:3783-3789.
5. Coffin, J. M. 1990. Retroviridae and their replication, p. 1437-1500. In B. N. Fields, D. M. Knipe, et al. (ed.), Virology. Raven Press, Ltd., New York, N.Y.
6. Coggins, L., N. L. Norcross, and S. R. Nusbaum. 1972. Diagnosis of equine infectious anemia by immunodiffusion test. Am. J. Vet. Res. 33:11-18.
7. Crawford, T. B., W. P. Cheevers, P. Klevjer-Anderson, and T. C. McGuire. 1978. Equine infectious anemia: virion characteristics, virus-cell interaction and host responses. ICN/UCLA Symp. Mol. Cell. Biol. 11:727-749.
8. Crawford, T. B., K. J. Wardrop, S. J. Tornquist, E. Reilich, K. M. Meyers, and T. C. McGuire. 1996. A primary production deficit in the thrombocytopenia of equine infectious anemia. J. Virol. 70:7842-7850.
9. Fujita, K., F. Maldarelli, D. F. Purcell, and J. Silver. 1994. Murine retroviral vector that induces long-term expression of HIV-1 envelope protein. J. Virol. Methods 50:293-311.
10. Gerencer, M., I. Valpotic, B. Jukic, M. Tomaskovic, and I. Basic. 1980. Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS. Arch. Virol. 104:249-257.
11. Hammond, S. A., S. J. Cook, D. L. Lichtenstein, C. J. Issel, and R. C. Montelaro. 1997. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71:3840-3852.
12. Harrer, T., E. Harrer, S. A. Kalams, P. Barbosa, A. Trocha, R. P. Johnson, T. Elbeik, M. B. Feinberg, S. P. Buchbinder, and B. D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156:2616-2623.
13. Henderson, L. E., R. C. Sowder, G. W. Smythers, and S. Oroszlan. 1987. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J. Virol. 61:1116-1124.
14. Irwin, M. J., L. S. Laube, V. Lee, M. Austin, S. Chada, C. G. Anderson, K. Townsend, D. J. Jolly, and J. F. Warner. 1994. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J. Virol. 68:5036-5044.
15. Issel, C. J., and L. D. Foil. 1984. Studies on equine infectious anemia virus transmission by insects. J. Am. Vet. Med. Assoc. 184:293-297.
16. Jolly, D. J., and J. F. Warner. 1991. Induction of anti-HIV-1 immune responses by retroviral vectors. Biotechnol. Ther. 2:179-193.
17. Kawakami, T., L. Sherman, J. Dahlberg, A. Gazit, A. Vaniv, S. R. Tronick, and S. A. Aaronson. 1987. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology 158:300-312.
18. Kono, Y. 1988. Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report. Arch. Virol. 98:91-97.
19. Kono, Y., K. Hirasawa, Y. Fukunaga, and T. Taniguchi. 1976. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inst. Anim. Health Q. 16:8-15.
20. Kozak, M. 1995. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc. Natl. Acad. Sci. USA 92:2662-2666. (Erratum, 92:7134, 1995.)
21. Kurago, Z. B., K. D. Smith, and C. T. Lutz. 1995. NK cell recognition of MHC class 1. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells. J. Immunol. 154:2631-2641.
22. Langemeier, J. L., S. J. Cook, R. F. Cook, K. E. Rushlow, R. C. Montelaro, and C. J. Issel. 1996. Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR. J. Clin. Microbiol. 34:1481-1487.
23. Lazary, S., D. F. Antczak, E. Bailey, T. K. Bell, D. Bernoco, G. Byrns, and J. J. McClure. 1988. Joint Report of the Fifth International Workshop on Lymphocyte Alloantigens of the Horse, Baton Rouge, Louisiana. 31 October-1 November 1987. Anim. Genet. 19:447-456.
24. McGuire, T. C., P. A. Lacy, and K. I. O'Rourke. 1990. cDNA sequence of the env gene of a pathogenic equine infectious anemia lentivirus variant. Nucleic Acids Res. 18:196.
25. McGuire, T. C., K. I. O'Rourke, T. V. Baszler, S. R. Leib, A. L. Brassfield, and W. C. Davis. 1994. Expression of functional protease and subviral particles by vaccinia virus containing equine infectious anaemia virus gag and 5′ pol genes. J. Gen. Virol. 75:895-900.
26. McGuire, T. C., K. I. O'Rourke, and L. E. Perryman. 1990. Immunopathogenesis of equine infectious anemia lentivirus disease. Dev. Biol. Stand. 72:31-37.
27. 8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68:1459-1467.
28. McGuire, T. C., W. Zhang, M. T. Hines, P. J. Henney, and K. M. Byrne. 1997. Frequency of memory cytotoxic T-lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. Virology 238:85-93.
29. McLachlin, J. R., N. Mittereder, M. B. Daucher, M. Kadan, and M. A. Eglitis. 1993. Factors affecting retroviral vector function and structural integrity. Virology 195:1-5.
30. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
31. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982.
32. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
33. Montelaro, R. C., J. M. Ball, and K. E. Rushlow. 1993. Equine retroviruses, p. 257-360. In J. A. Levy (ed.), The Retroviridae. Plenum Press, New York, N.Y.
34. Montelaro, R. C., W. G. Robey, M. D. West, C. J. Issel, and P. J. Fischinger. 1988. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J. Gen. Virol. 69:1711-1717.
35. Nakamura, Y., M. Kameoka, M. Tobiume, M. Kaya, K. Ohki, T. Yamada, and K. Ikuta. 1997. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 15:489-496.
36. O'Rourke, K., L. E. Perryman, and T. C. McGuire. 1988. Antiviral, antiglycoprotein and neutralizing antibodies in foals with equine infectious anemia virus. J. Gen. Virol. 69:667-674.
37. Ozaki, S., J. York-Jolley, H. Kawamura, and J. A. Berzofsky. 1987. Cloned protein antigen-specific, Ia-restricted T cells wilh both helper and cytolytic activities: mechanisms of activation and killing. Cell. Immunol. 105:301-316.
38. Payne, S. L., F. D. Fang, C. P. Liu, B. R. Dhruva, P. Rwambo, C. J. Issel, and R. C. Montelaro. 1987. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology 161:321-331.
39. Perryman, L. E., K. I. O'Rourke, P. H. Mason, and T. C. McGuire. 1990. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus. Immunology 71:592-594.
40. Perryman, L. E., K. I. O'Rourke, and T. C. McGuire. 1988. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62:3073-3076.
41. Petropoulos, C. J., and S. H. Hughes. 1991. Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells. J. Virol. 65:3728-3737.
42. Ray, J., and F. H. Gage. 1992. Gene transfer into established and primary fibroblast cell lines: comparison of transfection methods and promoters. BioTechniques 13:598-603.
43. Rettinger, S. D., S. C. Kennedy, X. Wu, R. L. Saylors, D. G. Hafenrichter, M. W. Flye, and K. P. Ponder. 1994. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91:1460-1464.
44. Rushlow, K. E. 1990. Evaluation of protective host immune responses during persistent infection with equine infectious anemia, p. 133-138. In M. Girard and L. Valette (ed.), Proceeding of the 5th Colloque des Cent Garde: Retroviruses of human AIDS and related animal diseases. Foundation Merieux, Lyon, France.
45. Siliciano, R. F., A. D. Keegan, R. Z. Dintzis, H. M. Dintzis, and H. S. Shin. 1985. The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones. J. Immunol. 135:906-914.
46. Song, W., E. W. Collisson, J. Li, A. M. Wolf, J. H. Elder, C. K. Grant, and W. C. Brown. 1995. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. Virology 209:390-399.
47. Sparer, T. E., S. G. Wynn, D. J. Clark, J. M. Kaplan, L. M. Cardoza, S. C. Wadsworth, A. E. Smith, and L. R. Gooding. 1997. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J. Virol. 71:2277-2284.
48. Tschetter, J. R., K. M. Byrne, L. E. Perryman, and T. C. McGuire. 1997. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies. Virology 230:275-280.
49. Warner, J. F., C. G. Anderson, L. Laube, D. J. Jolly, K. Townsend, S. Chada, and D. St. Louis. 1991. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. AIDS Res. Hum. Retroviruses 7:645-655.
50. Willbold, D., R. Rosin Arbesfeld, H. Sticht, R. Frank, and P. Rosch. 1994. Structure of the equine infectious anemia virus Tat protein. Science 264: 1584-1587.
51. Zheng, Y. H., H. Sentsui, T. Nakaya, Y. Kono, and K. Ikuta. 1997. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain. J. Virol. 71:5031-5039.
52. Ziegner, U. H., G. Peters, D. J. Jolly, S. J. Mento, J. Galpin, C. E. Prussak, J. R. Barber, D. E. Hartnett, C. Bohart, W. Klump, et al. 1995. Cytotoxic T-lymphocyte induction in asymptomatic HIV-1-infected patients immunized with retrovector-transduced autologous fibroblasts expressing HIV-1IIIB Env/Rev proteins. AIDS 9:43-50.